Continuous Manufacturing Teed Up As Disrupting Force In Pharma Sector
This article was originally published in The Tan Sheet
The question studied over the past decade – whether the industry should adopt continuous manufacturing – has been answered, and the new question is how best to implement it? Pharma firms have drafted a survival guide as they take advantage of continuous manufacturing and realize how it can transform an industry rooted in batch processing.
You may also be interested in...
Just as they did during the heparin crisis a decade ago, pharmaceutical companies must coordinate on coronavirus, Rx-360 CEO says.
As coronavirus spreads into China’s manufacturing region, quarantines and travel restrictions challenge international flow of pharmaceuticals, ingredients and personnel.
Final gene therapy IND CMC guidance clarifies expectations on process evolution, distinguishing drug substances from products, cGMP oversight and more.